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Telomeraseisareversetranscriptasespecializedintelomeresynthesis.Theenzymeisprimarilynuclearwhereitelongatestelomeres
butrecentreportshaveshownthatitalsolocalizestomitochondria.ThefunctionofTERTinmitochondriaislargelyunknownbut
the available ﬁndings point to a role in mitochondrial DNA metabolism. This paper discusses the available data on mitochondrial
telomerase with particular emphasis on its eﬀects upon the organellar DNA.
1.Introduction
Telomerase is a reverse transcriptase well recognized for
its function at telomeres, protein-DNA structures essential
for the stability of linear chromosomes. The enzyme is
composed minimally of two diﬀerent subunits, a catalytic
core (TERT) responsible for DNA catalysis and an RNA
component (TERC) that is used as template for telomeric
DNA synthesis. Whereas the RNA is present in both somatic
and germ cells constitutively, expression of TERT is tightly
regulated. Telomerase activity is high during embryogenesis
and in the vast majority of tumors but is low or non-existent
in most adult somatic cells [1]. Both TERT mRNA and
proteinhavebeenreportedintelomerase-negativecellsalbeit
at low levels [2, 3].
In recent years many diﬀerent reports have indicated
that the reverse transcriptase component of telomerase has
additional cellular functions beyond telomere stabilization.
For instance, TERT has been shown to play a role in
chromatin remodeling and in DNA damage response and
to act as a transcriptional modulator of the Wnt/beta-
catenin signaling pathways [4, 5]. More recently it was
shown to acquire properties of an RNA-dependent RNA
polymerase when in a complex with the RNA component
of the mitochondrial endoribonuclease MRP; such activity
is not involved in the maintenance of telomeres but rather in
regulation of gene expression [6].
In line with the idea that TERT has extratelomeric
functions, we were the ﬁrst to show that the human protein
(hTERT) is also mitochondrial [7, 8]. The mitochondrial
localization of endogenous and ectopically expressed hTERT
was subsequently reproduced by others [9–12]. The presence
of hTERT in mitochondria was surprising given the well-
established role of telomerase in telomere maintenance and
the lack of a telomeric structure on the mitochondrial
DNA (mtDNA). However, it was not entirely unexpected as
cytoplasmic localization of telomerase had been previously
reported [13–17] and, as described above, other func-
tions outside telomere maintenance have been increasingly
ascribed to hTERT.
This paper focuses on the localization of TERT to
mitochondria and its putative role in mtDNA metabolism.
We review ﬁndings regarding the eﬀects of mitochon-
drial hTERT upon genotoxic stress and recent evidence
demonstrating the impact of TERT (or lack thereof) to
mitochondrial biology under nonstress conditions. The
impact of mitochondrial telomerase to aging and telomere
maintenance is not discussed as it has been reviewed2 Journal of Nucleic Acids
elsewhere [18]. More information about the noncanonical
and/or extratelomeric activities of telomerase can be found
in other recent reviews [19–21].
2.MitochondrialLocalization of TERT
2.1. Endogenous and Ectopically Expressed TERT Are Mito-
chondrial. The ﬁrst evidence that TERT was a mitochondrial
protein came from studies done by us initially identifying a
mitochondrial-targeting signal (MTS) at its N-terminus [7].
Using software packages that predict MTSs, we identiﬁed
the ﬁrst 20 amino acid residues of TERT to be a putative
mitochondrial targeting peptide. We found the MTS to be
conserved among higher eukaryotes such as plants, ﬁsh, and
m a m m a l sb u tn o tp r e s e n ti nl o w e rs p e c i e ss u c ha sy e a s t
and tetrahymena [7]. Fusion of EGFP to the C-terminus
of full-length wild-type (WT) human TERT showed that
the recombinant protein was localized to mitochondria.
Addition of only the MTS to the N-terminus of EGFP
rendered the ﬂuorescent protein completely mitochondrial
and mutations of two amino acid residues within the MTS
abolished hTERT’s mitochondrial localization, indicating
that the MTS was suﬃcient and required to target hTERT
to mitochondria [7, 8]. Telomerase enzymatic activity was
alsodetectedinpuriﬁedmitochondrialextractsfromvarious
human cells [7], collectively providing strong evidence that
hTERT was a mitochondrial protein. Subsequently, others
have conﬁrmed the presence of endogenous hTERT in mito-
chondria by immunoﬂuorescence and Western blotting [9–
12]. Of note, a recent study showed that hTERT is found in
puriﬁed mitochondria of primary umbilical vein endothelial
cells [12], underscoring that the mitochondrial localization
of hTERT is not an artifact of protein overexpression or
associated with cellular transformation. In this context, our
unpublished work shows that a fraction of endogenous rat
and mouse TERT is mitochondrial as well (Green et al. in
preparation).
The content of hTERT in cancer cells has been estimated
to range from 20 to 50 molecules [22]. According to recent
reports [11, 12] and to our unpublished data, we estimate
that ∼10−20% of the total cellular hTERT is mitochondrial
under nonstress conditions, which is equivalent to 3−10
molecules of hTERT/mitochondrion at least in cancer cells.
It is not surprising then that many have missed the
mitochondrial localization of TERT. The unequal subcellular
distribution of dually targeted proteins is a wide spread
phenomenon and has been termed “eclipsed distribution”
[23].Manyoftheseproteinshavebeenshowntohavedistinct
functions in the diﬀerent subcellular compartments [23–26]
similar to what is predicted for TERT activity.
2.2. Submitochondrial Localization of TERT. To gain insight
into the molecular function of a mitochondrial protein
it is necessary to deﬁne its submitochondrial localization
since its presence in the mitochondrial membrane (inner or
outer) or in the matrix would predict diﬀerent biological
functions. Haendeler et al. [11] identiﬁed the submito-
chondrial localization of hTERT by immunoblots and co-
immunoprecipitations. The authors isolated mitochondria
from Hek293, treated the puriﬁed organelles with proteinase
K, and probed for hTERT by Western blots. Using this
approach they concluded that hTERT was mostly localized
to the mitochondrial matrix. Their claims were substan-
tiated by experiments demonstrating that overexpressed
myc-tagged hTERT co-immunoprecipitated with TOM20,
TOM40, and TIM23 [11]. TOM20, TOM40, and TIM23 are
protein translocases of the outer (TOM20 and TOM40) and
inner (TIM23) mitochondrial import machinery [24]. These
results are consistent with experiments showing that hTERT
binds mtDNA (see below), which resides in the matrix.
3. Regulation of hTERT’s
SubcellularDistribution
It is now recognized that the dual targeting of proteins
can be regulated, induced, or rebalanced in response to
cellular signaling or to changes in extracellular conditions
[26]. While much is still unknown about how the subcellular
distribution of TERT is achieved, the available data suggest
that it is tightly regulated. In this section, we review
publishedinformationregardingthesignalsthattargetTERT
to the nucleus and mitochondria and the role of oxidative
stress in redistributing hTERT within the cell. An excellent
review about mechanisms, regulation, and function of dual
targeting of proteins has been recently published [26].
3.1. TERT’s Targeting Signals. It is clear that at basal levels
TERT is primarily nuclear with only a small fraction present
in mitochondria. However, it is currently unknown what
regulates the intracellular distribution of TERT. In addition
to its N-terminal MTS, hTERT has a nuclear export signal
(NES) spanning amino acids 978−987 [14, 27]. Several
nuclear localization signals (NLSs) are predicted but they
have not yet been mapped out onto the protein [14]. No
splicing variants involving the MTS or the NES of hTERT
have been reported neither have variants that change its
subcellular distribution been identiﬁed. It therefore seems
likely that the dual targeting of TERT is based on a single
translation product containing diﬀerent targeting signals.
In such a case, the balance between the mitochondrial and
nuclear pools of the protein may be determined by various
competing factors, including the aﬃnity of each signal for its
target or, alternatively, the accessibility of the target signal for
speciﬁc receptor binding [26].
3.2. Regulation of TERT’s Distribution by Oxidative Stress.
The intracellular distribution of hTERT changes upon
speciﬁc stimuli, and many diﬀerent proteins have been
associated with its shuttling between nucleus and cytoplasm
(including mitochondria) [10, 12, 14, 16, 28–32]. Under
oxidative stress, the distribution of hTERT is regulated
by posttranslational modiﬁcations. Indeed, Src kinase has
been shown to control the export of hTERT from the
nucleus into the cytoplasm upon oxidative stress [10, 16].
Dephosphorylation of hTERT by the phosphatase Shp-2
reversedthisprocess[28].IncreasedlocalizationofhTERTto
mitochondria upon oxidative stress was also reported [10].Journal of Nucleic Acids 3
High levels of mitochondrial hTERT were observed within
hours of exposure to hydrogen peroxide (H2O2) but several
days were required in the case of hyperoxia. Although it took
weeks, this redistribution of hTERT under hyperoxia was
f o u n dt ob ear e v e r s i b l ep r o c e s s[ 10]. Together these data
suggest that the intracellular redistribution of hTERT under
oxidative stress likely relies on de novo protein synthesis but
thecurrentdatadonotexcludeproteinrelocalization.Carry-
ing out similar experiments in the presence of cycloheximide
will help clarify this issue.
B¨ uchner et al. [12] recently suggested that Src kinase also
controlsmitochondriallevelsofhTERTuponoxidativestress
similar to what has been shown for nuclear hTERT. The
authors found that while levels of WT hTERT decreased in
mitochondria upon H2O2 exposure, no changes occurred in
a mutant version of hTERT (Y707F) that is not phospho-
rylated by Src kinase. They concluded that oxidative stress
resultedintheSrc-dependentmitochondrialdownregulation
of hTERT [12].
While it is possible that Src is involved in regulating
nuclear and mitochondrial levels of hTERT under oxidative
stress, the above data should be taken with some caution.
The conclusions were based on targeting WT and Y707F
hTERT to mitochondria by cloning it into a mitochondrial
shooter vector, which essentially adds another MTS to the
N-terminus of hTERT [11]. However, no data showing the
degree of mitochondrial localization of this construct was
provided, which is required for proper interpretation of
the data since levels of hTERT were assayed in total lysates
prior to and after H2O2 treatment [12]. If under oxidative
stress TERT indeed relocalizes to mitochondria, lack of
complete mitochondrial localization of mitoTERT may skew
interpretation of the results. Assaying levels of mitoTERT
in isolated mitochondria under the same experimental
conditions [11] could easily address this concern.
Regardless of the role of Src, the downregulation of
mitochondrial hTERT could also stem from increased degra-
dation of hTERT, decreased aﬃnity of the mutant protein
for the mitochondrial import machinery, or promotion of
protein folding, which would compete for translocation
[23–26]. Clearly, additional studies are required to better
understandhowtheintracellulardistributionandmitochon-
drial localization of hTERT are regulated, and whether the
other stimuli reported to induce the subcellular shuttling
of hTERT also inﬂuence the balance between mitochondrial
and nuclear localization of the protein.
4 .h T ER Ta n dI t sR o l einm t D N AM et a bo l is m
Direct proof that TERT works in mtDNA metabolism
is still missing but the ability of hTERT to modulate
mtDNA damage induced by various agents, coupled with
the recent demonstration that hTERT binds to mtDNA,
strongly supports such a function. In this section we review
evidence that mitochondrial hTERT promotes, protects, or
does not interfere with mtDNA damage induced by diﬀerent
types of genotoxins. Taken together, the data indicate that
the modulation of mtDNA damage caused by TERT is
genotoxin-dependent and likely related to the type of lesion
present on the mtDNA. The exact mechanism(s) through
which hTERT modulates mtDNA damage has yet to be
elucidated. We also discuss ﬁndings about the interaction of
hTERT with the organellar DNA. However, we do not touch
on the role of hTERT in stress-mediated cell death as this has
been recently reviewed [18].
4.1. Mitochondrial hTERT Modulates Oxidative Damage
on the mtDNA. As reviewed above, oxidative stress alters
hTERT levels in mitochondria. Why under such conditions
mitochondrial hTERT levels ﬂuctuate is not clear but the
available data suggest that it may respond to oxidative
damage to mtDNA. Major controversy is observed regarding
modulation of oxidative stress-mediated mtDNA damage,
with evidence demonstrating that hTERT either exacerbates
or protects against this type of insult [7, 8, 10]. The reasons
for the opposing results are still unclear but they could
reﬂect diﬀerences in the cellular backgrounds, in antioxidant
defenses, and/or in the dose/length of the stress (see below).
We were the ﬁrst to show that hTERT modulates mtDNA
damage caused by H2O2 (200μM for either 15 minutes or
1 hour). Speciﬁcally, we demonstrated that cells expressing
WT hTERT were more sensitive to H2O2-mediated mtDNA
damage than the telomerase negative controls. Using 7
diﬀerent cell lines expressing ectopic or endogenous hTERT
and the respective non-hTERT isogenic controls, we showed
that levels of mtDNA damage were signiﬁcantly increased
by the presence of the WT protein [7]. The promotion of
damage was speciﬁc for hTERT because when hTERT was
cloned ﬂanked by lox p and excised using cre recombinase
the eﬀects were reversed [8]. All cells showed similar kinetics
of H2O2 breakdown; however, we detected an increase in
bioavailable iron in cells overexpressing hTERT [7]. Iron can
drive Fenton chemistry and more iron could increase the
levels of hydroxyl radical generation, potentially explaining
our results [7].
Subsequently, we established that the promotion of
H2O2-induced mtDNA damage was strictly dependent
on the presence of hTERT in mitochondria [8]. Stable
expression of a nonmitochondrial mutant (R3E/R6EhTERT)
completely abolished the promotion of mtDNA damage
caused by 200μMH 2O2, leading to levels of lesions that
were either not diﬀerent from or even below their non-
hTERT counterparts. Similar ﬁndings were observed using
a catalytically inactive hTERT mutant, indicating that the
promotionofmtDNAdamagereliedonreversetranscriptase
activity. These results were obtained in diﬀerent cellular
backgrounds, demonstrating that the eﬀects of mitochon-
drial hTERT were general and did not rely on a particular
cell type. Together, these data led to the conclusion that
telomerase must be active and in mitochondria to promote
H2O2-induced mtDNA damage [7, 8].
Interestingly, work by Ahmed et al. in 2008 contradicts
these ﬁndings. Using MRC-5 and MRC-5 stably express-
ing hTERT, they showed less damage in cells expressing
exogenous hTERT when compared to the non-hTERT
counterpart after treatment with 500μMH 2O2 for 3 hours.
A similar trend was observed for cells put under hyperoxia
conditions (40% oxygen) for up to 70 days. While levels of4 Journal of Nucleic Acids
hyperoxia-induced mtDNA damage plateaued in MRC-5
cells from days 20 to 70, in MRC-5 hTERT the mtDNA
damage was entirely eliminated after day 40, when hTERT
was solely mitochondrial localized [10]. These data suggest
that (i) mtDNA repair was either not operating or was
overwhelmedinMRC-5cellsbythe(likely)constantlevelsof
damageinducedbyhyperoxiaand(ii)thatrepairorturnover
of hyperoxia-induced mtDNA damage was modulated by
hTERT but only when the protein was in mitochondria. It is
worth noting that the protection aﬀorded by hTERT in this
study could result from upregulation of antioxidant defenses
since an increase in at least one antioxidant enzyme was
detected in MRC-5 hTERT by gene expression proﬁles [10].
4.2. Eﬀects of hTERT on mtDNA Damage Induced by Other
Genotoxins. Methyl methanesulfonate (MMS) is a methy-
lating agent that preferentially alkylates the N-7 position of
guanine. This lesion is converted into an abasic site and
transiently into a single DNA strand break (SSB, [33]).
Such lesions are repaired on the mitochondrial genome
through the base excision repair pathway (BER, [34]). When
hTERT overexpressing cells and their non-hTERT isogenic
counterparts were exposed to MMS, no diﬀerences in the
levelsofeithernuclearormtDNAdamagewereobserved.On
the contrary, the trend pointed to a decrease in damage in
both genomes in the presence of WT hTERT, which did not
reach statistical signiﬁcance [8].
As observed with H2O2, mtDNA damage induced by
etoposide was promoted by hTERT. Indeed, a slight but
signiﬁcant enhancement in mtDNA damage was observed
in NHF hTERT cells exposed to 1μM etoposide, which was
not observed in NHF controls [8]. Etoposide, like H2O2,n o t
only causes DNA double-strand breaks (DSBs) but induces
oxidative stress as well [35]. Note that the majority of
D N Ab r e a k sp r o v o k e db yH 2O2 are SSBs. In mitochondria,
oxidized DNA and SSBs are repaired by BER whereas to
date no system to correct DSBs has been identiﬁed in the
mammalian organelle [34].
Mitochondrial hTERT was also proposed to protect
mtDNA against UV damage. Using in vitro assays it was
shown that preincubation of isolated DNA with in vitro
translated hTERT protected the DNA against UV expo-
sure. To show that this eﬀect was physiologically relevant
and involved the mitochondrial function of TERT, lung
ﬁbroblasts from WT and TERT knockout (KO) animals
were exposed to increasing doses of UV and mitochondrial
function accessed based on the MTT assay. Signiﬁcantly
less MTT conversion was observed in the KO cells with
increasing doses of UV, leading to the conclusion that mito-
chondrial TERT protects mtDNA in vitro and mitochondrial
function in vivo from UV damage [11]. Since nuclear
TERT is also absent in the KO animals, further studies
are required to deﬁne whether the protection aﬀorded by
TERT against UV damage indeed relies on its mitochondrial
activity.
Likewise, expression of WT hTERT alleviated mtDNA
depletion caused by low doses of ethidium bromide (EtBr)
treatment. This rescue eﬀect was more pronounced with
expression of a mitochondrially targeted hTERT [11].
Potential mechanisms through which hTERT could be
protecting the mtDNA from damage induced by UV and
EtBr that cause, respectively, pyrimidine dimers and inter-
and intrastrand crosslinks are unknown. Repair systems
to remove these complex lesions have not been identiﬁed
in mitochondria [34]. Based on the notion that mtDNA
molecules containing nonrepairable lesions are targeted for
degradation, one could speculate that hTERT may promote
mtDNA turnover. Such activity is consistent with our
previouslyproposedroleforhTERTinmitochondrialquality
control [8]. Other proposed that means through which
TERT may modulate mtDNA damage are (i) modulation
of BER, (ii) increase in intracellular bioavailable iron, (iii)
changes in antioxidant defenses, and/or (iv) processing of
mitochondrial DSBs. More studies are required to deﬁne
the exact mechanism(s) through which TERT alters mtDNA
damage and, importantly, what kinds of lesions are impacted
by TERT.
4.3. hTERT Associates with mtDNA. If TERT was involved
in mtDNA metabolism, one would predict that it binds
mtDNA. Indeed, recent studies demonstrate that hTERT
interacts with the mitochondrial genome. Using chromatin
immunoprecipitations in cultured cells, Haendeler and col-
leagues demonstrated that hTERT interacts with mtDNA,
consistent with its presence in the mitochondrial matrix.
Surprising, however, was the fact that only two regions
of the mtDNA were pulled down with hTERT: ND1 and
ND2 of complex I [11]. Why only these two regions were
identiﬁed as bound to TERT, which has been shown to
have preference for telomeric DNA sequences [36], is not
clear. While mtDNA does not have a telomeric structure,
it does contain 22 telomeric-like repeats distributed across
the two strands of the genome [7]. Such sequences could
potentially be recognized by mitochondrial TERT and justify
the preference for ND1 and ND2 binding. However, analysis
of these gene sequences revealed no TTAGGG repeats
(data not shown). Other potential explanations for hTERT
association with mtDNA may relate to the oxidative state
of the mitochondria during the experiments or the use
of transient hTERT expression. Regardless, the binding of
hTERT to the mitochondrial genome certainly strengthens
its putative role in mtDNA metabolism. It will be interesting
to deﬁne whether other regions of the mtDNA bind to TERT
when the protein is stably expressed and, more importantly,
whether such interaction changes upon genotoxic stress.
5.TERTandMitochondrialBiology
MtDNA integrity is intimately related to mitochondrial
function. Once mtDNA is damaged, expression of critical
protein components of the electron transport chain (ETC)
is decreased leading to increased reactive oxygen species
(ROS) generation and decreased mitochondrial membrane
potential (ΔΨm ) .S u c he v e n t sl e a dt oav i c i o u sc y c l eo f
mitochondrial damage, ultimately aﬀecting mitochondrial
import, calcium homeostasis, and ATP production among
other processes [37–39]. Consistent with a role for TERT in
mtDNAmetabolism,recentworkhasshownthattheabsenceJournal of Nucleic Acids 5
of hTERT is associated with mitochondrial dysfunction. For
instance, cells lacking hTERT showed higher mitochondrial
ROS and decreased respiratory chain eﬃciency when com-
pared to controls [10, 11, 27]. This section reviews evidence
regarding the impact of hTERT on various mitochondrial
parameters under basal conditions. Together the data rein-
force the emerging role of hTERT in mitochondrial biology.
5.1. hTERT and ROS Production. Using mitoSOX and dihy-
drorhodamine (DHR) to detect mitochondrial superoxide
(O2
•−) and cellular peroxides (such as H2O2) it was shown
that ﬂuorescence from both dyes was decreased in MRC-5
hTERT cells when compared to MRC-5. These data indicate
that the presence of hTERT was associated with decreased
mitochondrial ROS production [10]. In agreement, overex-
pression of WT hTERT in Hek293 decreased levels of ROS
when compared to empty-vector control or a catalytically
inactivemutant[11].Incomplementaryexperiments,siRNA
knockdown of hTERT in HUVEC and Hek293 cells showed
increased production of O2
•− and H2O2, conﬁrming the
notion that hTERT lowers the basal levels of ROS generation
[10, 11].
Recently, we showed that expression of a mutant hTERT
(NES-hTERT) that is unable to shuttle between subcellular
compartments exhibited decreased mtDNA integrity and
increased mitochondrial ROS [27]. These data are consistent
with the above-mentioned work [10, 11] and suggest that
nonnuclear hTERT is associated with improved mitochon-
drial function. However, our data did not rule out the
possibility that the mitochondrial defects observed upon
expression of NES-hTERT were associated with the senescent
phenotype of the cells or to the defect in shuttling of hTERT
itself [27]. It is important to note that these data were
collected under nonstress conditions and therefore do not
contradict our previous ﬁndings which were obtained under
H2O2 exposure [7, 8]. Although it would be interesting to
submit NES-hTERT-expressing cells to oxidative stress, the
data obtained will need to be interpreted with caution given
the high degree of telomere damage and premature senes-
cence triggered by expression of this mutant hTERT [27].
5.2. hTERT and Respiratory Chain Activity. The energy
released by the transport of electrons through the ETC
also provides protons used to establish an electrochemical
gradient across the inner mitochondrial membrane [39].
Using JC-1 and confocal microscopy, it was shown that
MRC-5 hTERT cells had signiﬁcantly higher ΔΨma tn o r -
moxicconditionswhencomparedtoitsisogenicnon-hTERT
control[10].H owever ,thisseemedinapparentcontradiction
with the lower levels of ROS in these cells given there is more
chance of ROS generation when the ΔΨmi sh i g h[ 40, 41].
The authors suggested that the mitochondria of hTERT cells
are tightly coupled, which explains the low ROS levels [10].
Indeed we recently showed that cells expressing WT hTERT
have highly coupled mitochondria [27].
The activity of the ETC was directly evaluated using
cells expressing either WT hTERT or a catalytically inactive
mutant. Overall succinate-dependent respiratory function
was 30% lower in the mutant while complex I activity
was higher in cells carrying the WT protein. The increased
respiratory capacity detected in cultured cells was conﬁrmed
in vivo. Respiratory function in intact heart and liver
mitochondria isolated from WT and KO TERT animals
was analyzed. Complex I activity was lower in the heart
of the KO animals; however, no changes were detected in
liver mitochondria. These data led to the hypothesis that
in vivo the impact of mitochondrial TERT may be more
prominent in cells that have high-energy requirements and
less regenerative capacity [11].
The improvement in complex I function was attributed
to the direct binding of hTERT to ND1 and ND2, which
could potentially increase expression of these proteins [11].
Recent data in yeast suggest that enhanced mitochondrial
respiration may be mediated by increased number of oxida-
tive phosphorylation (OXPHOS) complexes per organelle as
opposed to increasing the total number of mitochondria per
cell [42]. It will be interesting to test whether this is the case
inmammaliancellsand,ifso,whichOXPHOScomplexesare
modulated by hTERT in mitochondria.
Two TERT KO mouse models have been generated, and
no gross defects have been observed in early generations
[43, 44], inconsistent with a major role for TERT in mtDNA
metabolism. It is important to note that results observed
with cells grown in culture were mild, and it is possible that
subtlediﬀerenceshavebeenoverlookedwhennotspeciﬁcally
investigating mitochondrial function in these animals. Alter-
natively, it is feasible that compensatory mechanisms were
activated in the KO animals. Interestingly, late generation
mTERT KO animals had accelerated infertility, which was
initially ascribed to the short telomeres present in the
animals.However,miceheterozygousforTERT,whilehaving
very short telomeres, did not show the same phenotype,
leading the authors to conclude that the dosage of TERT
was important for genomic stability [45]. It is known that
proper mitochondrial function plays an important role in
fertility [46]. In light of the latest ﬁndings, it is tempting
to speculate that the impact of the lack of mitochondrial
TERT contributed to the infertility previously observed in
the KO animals. Certainly, it seems worth revisiting the
mouse models available to address whether mitochondrial
abnormalities are present in these animals. Of particular
interest will be to measure mitochondrial function in the
KO animals under conditions that require a high-energy
demand. Of note, TERT KO animals have been submitted to
physical exercise, and an important role for telomerase has
been ascertained in the heart and in aortic endothelial cells
[47, 48]. However, no direct assessment of mitochondrial
function such as cytochrome c oxidase activity or ATP
production was conducted nor was a connection to mito-
chondrial biology or to telomerase function in mitochondria
established [47, 48], all worth addressing in future studies.
6. Concluding Remarks
Mitochondrial function is key to cellular homeostasis, and
maintenance of mitochondrial quality has major impact in
healthanddisease.AroleforTERTinmitochondriaisclearly6 Journal of Nucleic Acids
emerging although its exact mechanism of action remains
largely unknown. Years of work done in vitro and in vivo
have established telomerase as a main player in aging and
cancer primarily due to its action upon the telomeres. The
mitochondrial localization and function of TERT bring yet
another layer of complexity to the already intricate scenario
of telomerase multitasking in the cell. More experiments are
certainly required to diﬀerentiate the mitochondrial eﬀects
of TERT as dependent on its nuclear versus mitochondrial
localization and to establish the biological signiﬁcance of
TERT in mitochondria in vivo. The next years will be very
exciting for both the mitochondrial and telomerase ﬁelds as
more details about the function of TERT in the organelle are
unveiled. Such studies will allow for a better understanding
of the overall role of telomerase in cellular function and will
lay foundation for new therapeutic approaches to aging, age-
and mitochondrial-related diseases, and cancer.
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